Quarter 1, 2012
Prostate Cancer
Diagnosis, Prognostic Factors, and Treatment Considerations
Features
Drug and Administration Compendia
Coding, reimbursement, and available therapies
View PDF
Drug Therapy Review
Tany Dorff, M.D., USC Norris Comprehensice Cancer Center
View PDF
Improving Value
Michele Feehily, IntrinsiQ,an AmerisourceBergen Specialty Group Company
View PDF
Industry Thought Leaders
Patrick Gill, Pharm.D., and William Noorigian, Pharm.D., Horizon BCBSNJ
View PDF
Download
For your convenience, download the entire PDF to your computer
View PDF
Departments
Correspondence
Kjel A. Johnson, PharmD, Publisher, ManagedCare Oncology
View PDF
Pipeline
Howard "Skip" Burris III, MD, Director of Drug Development at Sarah Cannon Research Institute
View PDF
Clinical Trials Update
John W. Mucenski, BS, PharmD, Director of Pharmacy Operations at UPMC Cancer Centers
View PDF
Regulatory and Reimbursement
Denise K. Pierce, President, DK Pierce & Associates, Inc.
View PDF
Facts and Figures
Data and accompanying graphics on reimbursement practices, information management, and oncology spending
View PDF
Resources and References
A comprehensive list of information sources relevant to managed care oncology professionals.
View PDF
